NEW YORK, Nov. 30, 2016 /PRNewswire/ -- Investigators are looking for different molecular entities that could be used forthe development of viable therapeutics with commercial potential. Peptide therapeutics are one such category that has gained significant attention in past years. Several products have been launched in global market for different indications. Significant
Pharmacological profiles of peptide therapeutics is quite good due to which their numbers are increasing in global market. Inherently, peptide therapeutic offers various benefits like higher safety and efficacy levels along with higher tolerability. Metabolism of peptide therapeutics is quite predictable and it can be changed by investigators. In this way, higher control over pharmacological parameters could be observed. They can also be developed synthetically due to which variability could be made during their development. In this way, they are highly malleable and could be changes according to the requirements of drug development program. Their rate of development is high and low attrition rates related to peptide therapeutics have been also observed.
Pipeline of peptide therapeutics is quite strong due to which new products are expected to enter in global market in coming years. Several peptide therapeutics have already entered in various phases of clinical trials. Development of positive results will accelerate their market introduction in coming years. They are peptide in nature due to which chances of degradation is high, poor chemical stability and absorbance are some common caveats with their development. Immunogenicity is another factor that affect the efficacy of peptide therapeutics as some patients may develop severe side effects. Investigators have developed various procedure by which they are able to increase potency of peptide products. In this way, it could be observed that investigators are actively engaged in the development of peptide therapeutics.
Rapid discovery of peptide therapeutics is expected to increase the number of products in global market. Investigators are developing methods to identify new lead molecules that will serve as a basis for the development of new molecule. They are also being administrated in combination with other drugs to achieve higher therapeutic benefits. Alternate Route of Administration (RoA) is also being discovered for peptide drugs so as to maintain their efficacy. They are expected to have competition with small molecule drugs and development of new technologies which can hamper their marketing potential. Higher prices are other major factors that affect the commercialization potential of peptide therapeutics in global market. These factors have to consider by pharmaceutical companies while formulating marketing strategies.Peptide therapeutics are versatile in nature due to which they can be used for the treatment of various disorders. Cancer, Central Nervous System (CNS), cardiovascular diseases, respiratory diseases and metabolic disorders are some the major segments where presence of peptide therapeutics could be observed. Besides this, different types of insulin has been developed by engineering peptide molecules. Their pharmacological efficacy is expected to be improved with time and new molecules are expected to enter in global market. Pharmaceutical companies have to come forth with new molecules in order to increase market shares of peptide therapeutics. Strong clinical pipeline indicates that the pharmaceutical firms are actively engaged in the development of peptide therapeutics. In this way, it could be expected that market size of global peptide therapeutics market will increase in coming years.Peptide Segment Included In Report:Cyclic-Peptide, Polypeptide, Glycopeptide, Oligopeptide, Depsipeptide, Neuropeptide, Dipeptides, Natriuretic Peptide, Lipopeptide, Opioid Peptide, Peptide Vaccine, Antimicrobial Cationic Peptide & Insulin"Global Peptide Therapeutics Market & Clinical Pipeline Insight 2016" Report Highlights:Introduction to PeptidesMechanism of Action: Peptide Therapeutics, Peptide Vaccine & Peptide HormoneGlobal Peptide Therapeutics Market DynamicsGlobal Peptide Clinical Pipeline by Company, Indication & PhaseGlobal Peptide Pipeline: 722 PeptidesMajority Peptides in Preclinical Phase: 308 PeptidesCommercially Available Peptides: 136 PeptidesRead the full report: http://www.reportlinker.com/p04397346-summary/view-report.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: [email protected]US: (339)-368-6001Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-peptide-therapeutics-market--clinical-pipeline-insight-2016-300370816.html
Subscribe to our Free Newsletters!
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...
Reflux nephropathy is the scarring and damage caused to the kidneys by reverse flow of urine from ...View All